STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries
WASHINGTON — The Biotechnology Innovation Organization is joining the legal fight against the Trump administration’s pilot program aimed at aligning drug prices in Medicare with prices charged in peer countries.
Key points
- BIO and two California-based biotech trade groups filed a complaint Friday in the U.S.
District Court for the Northern District of California asserting that the Global Benchmark for Efficient Drug Pricing demonstration, known as GLOBE, oversteps Medicare’s statutory authority.
The Centers for Medicare and Medicaid Services did not immediately respond to a request for comment.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.